We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

In what will be an insightful and captivating presentation in Enderby, hear from Dr. Kim Christie as she speaks about healthy ...

In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...

Having these warning signs checked out could provide an opportunity to delay or even prevent the onset of dementia or Alzheimer's.

Right now across the country, tens of millions of older adults and people with serious disabilities have a choice to make: whether to stick with their current Medicare option, or change during Open ...

Three Lowcountry siblings say they are remembering their father as they work to help other families whose loved ones are living with dementia.

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

David Lee VanHoy David Lee VanHoy passed away on Sept. 5, 2024 in Orange County from complications with Alzheimer’s disease. He was born on Dec. 27, 1953 ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Politicians, like everyone else, age. Some will develop Alzheimer's disease or dementia. How worried should we be about ...